Autonomix Raises $2.5M Through Immediate Exercise Of Warrants At Reduced Price Of $1.723 Per Share Under Registered Offering

Author: Benzinga Newsdesk | July 22, 2025 08:33am

Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into agreements with certain holders of its existing warrants for the immediate exercise (or prepayment of the exercise price) of certain outstanding warrants to purchase up to an aggregate of 1,477,596 shares of common stock of the Company originally issued in November 2024 at a reduced exercise price of $1.723 per share. The shares of common stock issuable upon exercise of the outstanding warrants are registered pursuant to an effective registration statement on Form S-1 (File No. 333-282940). The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $2.5 million, before deducting placement agent fees.

Posted In: AMIX